KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $1.7 billion.

  • Incyte's Total Liabilities fell 880.14% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 880.14%. This contributed to the annual value of $2.0 billion for FY2024, which is 2539.92% up from last year.
  • Incyte's Total Liabilities amounted to $1.7 billion in Q3 2025, which was down 880.14% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Incyte's Total Liabilities ranged from a high of $2.1 billion in Q1 2025 and a low of $933.6 million during Q1 2021
  • Its 5-year average for Total Liabilities is $1.5 billion, with a median of $1.5 billion in 2023.
  • In the last 5 years, Incyte's Total Liabilities skyrocketed by 3043.16% in 2024 and then crashed by 880.14% in 2025.
  • Over the past 5 years, Incyte's Total Liabilities (Quarter) stood at $1.2 billion in 2021, then increased by 26.43% to $1.5 billion in 2022, then grew by 8.25% to $1.6 billion in 2023, then rose by 25.4% to $2.0 billion in 2024, then dropped by 15.9% to $1.7 billion in 2025.
  • Its Total Liabilities was $1.7 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $2.1 billion in Q1 2025.